Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
Title | FOA | Organization | Release Date | Expire Date | Purpose |
---|---|---|---|---|---|
NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Patient-Oriented Research Career Development award (K23 - Clinical Trial Required) | PAR-24-220 | NINDS | The purpose of this NIH HEAL Initiative PAINCare Clinician Training Program (PCTP): Mentored Patient-Oriented Research Career Development award (K23) (Clinical Trial Required) is to support a cohort… More | ||
NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Required) | PAR-24-217 | NINDS | The purpose of this NIH HEAL Initiative PAIN Care Clinician Training Program: PCTP): Mentored Clinical Scientist Development Awards (K08) (Clinical Trials Required) is to support a cohort of new and… More | ||
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | PAR-24-293 | NINDS | The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical… More | ||
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) | PAR-24-294 | NINDS | Reissue PAR-21-233 - The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through… More | ||
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) | PAR-25-133 | NINDS | This announcement encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the… More | ||
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed) | PAR-24-228 | NINDS | (Reissue of PAR-18-490, PAR-21-234) The purpose of the NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) is to diversify the pool of independent neuroscience… More | ||
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Basic Experimental Studies with Humans Required (BESH)) | PAR-24-227 | NINDS | The purpose of the Maximizing Opportunities for Scientific and Academic Independent Careers(MOSAIC) program is to support a cohort of early career, independent investigators from diverse backgrounds… More | ||
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Required) | PAR-24-229 | NINDS | (Reissue of PAR-18-486, PAR-21-153) The purpose of the NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) is to diversify the pool of independent neuroscience… More | ||
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required) | PAR-24-226 | NINDS | The purpose of the Maximizing Opportunities for Scientific and Academic Independent Careers(MOSAIC) program is to support a cohort of early career, independent investigators from diverse backgrounds… More | ||
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) | PAR-25-327 | NINDS | The Ultra-Rare Gene-Based Therapy (URGenT) network supports Investigational New Drug (IND)-enabling studies and planning activities for First-in-Human (FIH) clinical testing of gene-based or… More |